Steris outlines 7%-8% organic revenue growth for fiscal 2026 amid tariff headwinds and resilient demand
Source: SeekingAlpha
2026-02-05 10:55:11 ET
More on Steris
- STERIS plc (STE) Q3 2026 Earnings Call Transcript
- Steris Q3 2026 Earnings Preview
- Short bets on S&P 500 Healthcare sector rises to 2.00% in October; MRNA stays most shorted stock
- Seeking Alpha’s Quant Rating on Steris
- Historical earnings data for Steris
Read the full article on Seeking Alpha
For further details see:
Steris outlines 7%-8% organic revenue growth for fiscal 2026 amid tariff headwinds and resilient demand
STERIS plc (Ireland)
NASDAQ: STE
STE Trading
-3.34% G/L:
$223.835 Last:
382,616 Volume:
$227.73 Open:
STE Latest News
January 21, 2026 04:30:00 pm
STERIS to Host a Conference Call for Fiscal 2026 Third Quarter Results on February 5, 2026
STE Stock Data
$24,146,561,530
97,094,275
N/A
428
N/A
Medical Equipment & Supplies
Healthcare
IR
Dublin 2
